Caroline E. Nunes-Xavier

Mum 👯‍♀️ and Scientist 👩🏻‍🔬🔬From Oslo 🇳🇴

[ASEICA @ASEICAnews]

🔬💊 This year we are delighted to merge ASEICA Joven and Med Retreats!

✅This session is an opportunity to learn from one another and talk about tumour microenvironment and immunotherapy!

📍 Carlos Valdivia @Caroliten2 @JaviVaquero84 and Lorena Pérez-Gutiérrez

#ASEICACongress

[Caroline E. Nunes-Xavier @Caroliten2]

⚡️🎯Our findings highlight B7-H3 pan-cancer molecule as an actionable novel immune checkpoint protein in ccRCC alone or in combination with tyrosine kinase inhibitors🎯⚡️

[Caroline E. Nunes-Xavier @Caroliten2]

🎯🔬It is my immense pleasure to share that we have published this collaborative work on the impact on B7-H3 immune checkpoint protein in metastatic renal cancer 🔬🎯

Full article: https://t.co/YFeXpuVBPQ

[Leire Torices @LeireTorices]

Latest work from my thesis, on how protein synthesis influences PTC readthrough efficiency in PTEN and its isoforms 🛑🧬 #stopcodons #readthrough #PTEN https://t.co/VSYmkuEQAG #mdpicancers vía @Cancers_MDPI

[Caroline E. Nunes-Xavier @Caroliten2]

🎯🔬 We are very excited to share our latest results on the molecular, functional and clinical characterization of B7-H5/VISTA immune checkpoint protein in metastatic renal cancer.  🔬🎯https://t.co/3E6ZxonL9C @biobizkaia @SaludISCIII @Oslounivsykehus @iScience_CP @CellPressNews

[Caroline E. Nunes-Xavier @Caroliten2]

ESTAMOS DE ENHORABUENA EN BIOBIZKAIA por el apoyo de @FEDER_ONG a la investigación sobre el Síndrome CTNNB1 @ctnnb1_espana👩‍🔬🧬🔬@biobizkaia @CIBERER

[FEDER | Enfermedades Raras @FEDER_ONG]

🔬 #FundaciónFEDER impulsa 7 investigaciones en #EnfermedadesRaras gracias a su VIII Convocatoria de Ayudas.

🤝 Desde 2015, reforzamos nuestro compromiso con la investigación biomédica y apoyamos a los investigadores y a las organizaciones de pacientes que trabajan juntos.

[Caroline E. Nunes-Xavier @Caroliten2]

ESTAMOS DE ENHORABUENA EN BIOBIZKAIA por el apoyo de @FEDER_ONG a la investigación sobre el Síndrome CTNNB1 @ctnnb1_espana👩‍🔬🧬🔬@biobizkaia @CIBERER

[Asociación Ctnnb1 España @ctnnb1_espana]

Estos premios apoyan la investigación biomédica 👨‍⚕️ de estas patologías, y apoya a los investigadores y a las organizaciones de pacientes que trabajan conjuntamente en la búsqueda de avances en el diagnóstico y tratamiento para las enfermedades raras.

Proyecto ⤵️

[Caroline E. Nunes-Xavier @Caroliten2]

Grateful for attending three days of  inspiring #EMBOLabLead workshop together with wonderful Lab Leader colleagues. Thanks to #EACRnews  @LeadSculpt

[Caroline E. Nunes-Xavier @Caroliten2]

Today on World Prostate Cancer Day we would like to share hopes on emerging new therapies for prostate cancer https://t.co/gsyQmnCrdl #WorldProstateCancerDay @biobizkaia

[Caroline E. Nunes-Xavier @Caroliten2]

💥 Delighted to share our latest mini-review: 🎯 B7-H3: a robust target for immunotherapy in prostate cancer 🎯 ⛳ HOT OFF THE PRESS in @trendscancer @biobizkaia @Oslounivsykehus https://t.co/9DYQdzqP19

[Caroline E. Nunes-Xavier @Caroliten2]

🔎Check out the inspiring special issue on checkpoints in Translational Oncology 💡
https://t.co/4p6zsBu0eC

[Steam Botikazar @BotikazarSTEAM]

M12. Esther Rey & Caroline Nunes-Xavier Bio-Bizkaia Institutuko ikerlariek minbiziaren aurkako ikerkuntza-lerroak eta lan zientifikoa KZ-ko ikasle batzuei azaldu zizkieten. Andrea Castro, Minbiziaren Aurkako Elkartearen langilea elkartearen lanaz eta garrantziaz mintzatu zen.

[Caroline E. Nunes-Xavier @Caroliten2]

@Nonijurado En Oslo, Noruega “PARADIS”

[RTVEPaisVasco @RTVEPaisVasco]

En Euskadi se diagnostican 50 nuevos casos de cáncer infantil cada año. Nos acercamos a los investigadores de #osakidetza y a las asociaciones que trabajan con los menores y sus familiares. @OSIEECruces @biobizkaia @JunerenHegoak #DiaInternacionalCancerInfantil @osakidetzaEJGV

[ESMO IOTECH @esmo_iotech]

📢Check out this latest original article @Caroliten2 & colleagues @biobizkaia @Oslounivsykehus @nanostringtech @UEuropea

🔬Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome

Available #OpenAccess👇
https://t.co/Qc9b6rnsEX

[Leire Torices @LeireTorices]

If you wonder how premature termination codons can affect your protein of interest and how you can mitigate their consequences with translational readthrough, in our recently published protocol from my thesis you can get an idea of ​​it 😊 #stopcodons https://t.co/uOOTh2Nk8V

[The New Yorker @NewYorker]

Inside this week’s issue of The New Yorker: https://t.co/hJGeB6xJx7

[Caroline E. Nunes-Xavier @Caroliten2]

https://t.co/lrTNzf2Z6e

[Caroline E. Nunes-Xavier @Caroliten2]

Have you defended your Doctoral thesis in 2022/23, and are looking for an Immuno-Oncology laboratory to present a Juan de la Cierva application? Perhaps you would like to join my emerging group in Immuno-Oncology @biobizkaia ? Contact me if you are interested.